[ad_1] USFDA Issues Post-Application Action Letter to Dr Reddy’s Biologics Unit We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok [ad_2] Source link
[ad_1] Dr Reddy’s Denosumab Biosimilar AVT03 Faces USFDA Setback After Plant Inspection We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok [ad_2] Source link
[ad_1] The division bench of the Delhi High Court on Friday declined to stay a single-judge order permitting Dr. Reddy’s Laboratories to export its version of semaglutide to countries where Danish drug maker Novo Nordisk does not hold a patent for the diabetes and anti-obesity drug. A bench led by Justice Hari Shankar observed that…
[ad_1] Semaglutide Patent Clash: Delhi HC Denies Novo Nordisk Injunction, Manufacturing by Dr Reddy’s to Continue We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok [ad_2] Source link
[ad_1] Dr Reddy’s Laboratories has received marketing approval from the European Commission (EC) for AVT03, a biosimilar of Prolia (denosumab) and Xgeva (denosumab) prescribed in the treatment of bone related conditions, the company said in a statement on Monday. The authorisation clears the way for commercial launch across all EU member states as well as…
[ad_1] NPPA Fixes Retail Prices for 28 Drug Formulations Including Dapagliflozin, Telmisartan, Amoxycillin, Details We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok [ad_2] Source link
[ad_1] Indian firms that make active pharmaceutical ingredients, or APIs, are gearing up to supply the basic ingredient that goes in making copies of Novo Nordisk A/S’s weight-loss drugs that are losing patent protection next year in several large markets. From local giants Dr Reddy’s Laboratories Ltd. to suppliers like Macleods Pharmaceuticals Ltd., Indian firms…
[ad_1] NPPA Fixes Retail Prices of 42 Formulations Including Amoxycillin, Dapagliflozin, Cefixime We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok [ad_2] Source link
[ad_1] Natco vs Novo Nordisk: Delhi High Court Directs Mediation in Wegovy Patent Dispute We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok [ad_2] Source link
[ad_1] Dr Reddy’s Secures CDSCO Panel Approval to Import, Market Olutasidenib for AML We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok [ad_2] Source link